XML 19 R7.htm IDEA: XBRL DOCUMENT v3.26.1
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Preferred Stock
Common Stock
Treasury Stock
Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Beginning balance at Dec. 31, 2024 $ 1,404,238 $ 0 $ 18 $ (507,598) $ 1,231,435 $ 669,336 $ 11,047
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Exercise of stock options, vesting of restricted stock, and related tax withholdings (5,436)       (5,436)    
Stock-based incentive compensation 8,801       8,801    
Purchase of company stock, and related tax effects (101,113)     (101,113)      
Net income 46,742         46,742  
Other comprehensive loss (2,398)           (2,398)
Ending balance at Mar. 31, 2025 1,350,834 0 18 (608,711) 1,234,800 716,078 8,649
Beginning balance at Dec. 31, 2024 1,404,238 0 18 (507,598) 1,231,435 669,336 11,047
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 97,265            
Other comprehensive loss (4,082)            
Ending balance at Jun. 30, 2025 1,359,948 0 18 (659,115) 1,245,479 766,601 6,965
Beginning balance at Mar. 31, 2025 1,350,834 0 18 (608,711) 1,234,800 716,078 8,649
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Exercise of stock options, vesting of restricted stock, and related tax withholdings (33)       (33)    
Stock-based incentive compensation 10,712       10,712    
Purchase of company stock, and related tax effects (50,404)     (50,404)      
Net income 50,523         50,523  
Other comprehensive loss (1,684)           (1,684)
Ending balance at Jun. 30, 2025 1,359,948 0 18 (659,115) 1,245,479 766,601 6,965
Beginning balance at Dec. 31, 2025 1,326,393 0 18 (818,201) 1,263,549 876,921 4,106
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Exercise of stock options, vesting of restricted stock, and related tax withholdings (12,595)       (12,595)    
Stock-based incentive compensation 10,199       10,199    
Purchase of company stock, and related tax effects (17,539)     (17,539)      
Net income 45,343         45,343  
Other comprehensive loss (732)           (732)
Ending balance at Mar. 31, 2026 1,351,069 0 18 (835,740) 1,261,153 922,264 3,374
Beginning balance at Dec. 31, 2025 1,326,393 0 18 (818,201) 1,263,549 876,921 4,106
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 99,256            
Other comprehensive loss (1,874)            
Ending balance at Jun. 30, 2026 1,259,898 0 18 (987,296) 1,268,767 976,177 2,232
Beginning balance at Mar. 31, 2026 1,351,069 0 18 (835,740) 1,261,153 922,264 3,374
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Exercise of stock options, vesting of restricted stock, and related tax withholdings (768)       (768)    
Stock-based incentive compensation 8,382       8,382    
Purchase of company stock, and related tax effects (151,556)     (151,556)      
Net income 53,913         53,913  
Other comprehensive loss (1,142)           (1,142)
Ending balance at Jun. 30, 2026 $ 1,259,898 $ 0 $ 18 $ (987,296) $ 1,268,767 $ 976,177 $ 2,232